Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avastin and doxorubicin as postoperative therapy for anaplastic thyroid carcinoma
2007-001783-75Phase 2Completed
- Sponsor
- Skåne University Hospital
- Start
- Jan 2008
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of bevacizumab and doxorubicin in anaplastic thyroid cancer (ATC), sponsored by Skåne University Hospital. Primary endpoint: overall survival. Started Jan 2008; status: completed.
02
Drugs
bevacizumabdoxorubicin
03
Conditions
anaplastic thyroid cancer (ATC)
Beyond the preview
Go deeper on 2007-001783-75.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001783-75.